{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:09:54Z","timestamp":1789420194659,"version":"build-2803163510"},"reference-count":47,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100012112","name":"Swedish Orphan Biovitrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012112","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["acrjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Arthritis &amp; Rheumatology"],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>DISSOLVE I and II examined the efficacy and safety of nanoencapsulated sirolimus (NAS) plus pegadricase (NASP) in patients with uncontrolled gout (UG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In these double\u2010blind, placebo\u2010controlled Phase 3 trials of NASP, patients were randomized 1:1:1 to infusions of high\u2010dose (HD) or low\u2010dose (LD) NAS plus pegadricase (HD NASP, LD NASP, respectively) or placebo, given every 4 weeks for 6 doses. The primary endpoint was proportion of patients with serum urate (SU) &lt; 6 mg\/dL for \u2265 80% of the time during Weeks 21\u201324. Secondary endpoints included health\u2010related quality of life, tophus resolution, tender joints, and gout flares. Safety was also assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 265 patients received HD NASP, LD NASP, or placebo. SU response during weeks 21 to 24 was significantly higher with NASP than with placebo (HD NASP: 51%; LD NASP: 43%; placebo: 8%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001 for both doses vs placebo). Common adverse events included gout flares (HD NASP: 42.5%; LD NASP: 44.3%; placebo: 43.3%), infections (HD NASP: 23.0%; LD NASP: 18.2%; placebo: 16.7%), and stomatitis (HD NASP: 9.2%; LD NASP: 3.4%; placebo: 0%). Infusion reactions within 1 hour were infrequent (4%) in NASP\u2010treated patients. During weeks 1 to 12, the proportion of patients with flares was similar between NASP\u2010 and placebo\u2010treated patients; thereafter, it decreased in NASP\u2010treated patients but remained unchanged with those receiving the placebo.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>NASP treatment resulted in a significantly higher proportion of patients with complete SU response during weeks 21 to 24 compared with placebo and was generally well tolerated. NASP, an every\u20104\u2010week treatment, can markedly alleviate disease burden in patients with UG.<\/jats:p>\n                    <jats:p>\n                      <jats:boxed-text content-type=\"graphic\" position=\"anchor\">\n                        <jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" mimetype=\"image\/png\" position=\"anchor\" specific-use=\"enlarged-web-image\" xlink:href=\"graphic\/art70266-gra-0001-m.png\">\n                          <jats:alt-text>image<\/jats:alt-text>\n                        <\/jats:graphic>\n                      <\/jats:boxed-text>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/art.70266","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:10:21Z","timestamp":1782447021000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and Safety of Nanoencapsulated Sirolimus Plus Pegadricase: Results From the Randomized, Placebo\u2010Controlled Phase 3 Trials"],"prefix":"10.1002","author":[{"given":"Herbert S. B.","family":"Baraf","sequence":"first","affiliation":[{"name":"The Center for Rheumatology and Bone Research  Wheaton Maryland"},{"name":"Division of Rheumatology The George Washington University  Washington DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja P.","family":"Khanna","sequence":"additional","affiliation":[{"name":"Division of Rheumatology University of Michigan  Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Petronijevic","sequence":"additional","affiliation":[{"name":"Clinic of Rheumatology Military Medical Academy  Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamuka","family":"Lortkipanidze","sequence":"additional","affiliation":[{"name":"V. Tsitlanadze Scientific\u2010Practical Centre of Rheumatology  Tbilisi Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Patel","sequence":"additional","affiliation":[{"name":"Conquest Research  Winter Park Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwabena","family":"Ayesu","sequence":"additional","affiliation":[{"name":"Omega Research Maitland  Orlando Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3168-1542","authenticated-orcid":false,"given":"Michael H.","family":"Pillinger","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine New York University Grossman School of Medicine  New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Singhal","sequence":"additional","affiliation":[{"name":"Southwest Rheumatology Research  Dallas Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Sobierska","sequence":"additional","affiliation":[{"name":"Sobi (former employee)  Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquie","family":"Christie","sequence":"additional","affiliation":[{"name":"Sobi  Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Traber","sequence":"additional","affiliation":[{"name":"Sobi Inc.  Waltham Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehan","family":"Azeem","sequence":"additional","affiliation":[{"name":"Sobi Inc.  Waltham Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley","family":"DeHaan","sequence":"additional","affiliation":[{"name":"Sobi Inc.  Waltham Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Santin\u2010Janin","sequence":"additional","affiliation":[{"name":"Sobi  Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavisha","family":"Desai","sequence":"additional","affiliation":[{"name":"Sobi Inc.  Waltham Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Kivitz","sequence":"additional","affiliation":[{"name":"Altoona Center for Clinical Research  Duncansville Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.9501"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(24)00117-6"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0115-y"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00569-9"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.43215"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24180"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209707"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23803"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-020-00260-1"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.071229"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2018.1532904"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-10-117"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1169"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-023-00546-0"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-023-01006-3"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1586\/eci.10.90"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4497"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42335"},{"key":"e_1_2_8_20_1","volume-title":"Prescribing information","author":"Methotrexate","year":"2020"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05363-2"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206410"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27945-7"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-025-02267-w"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00969"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nnano.2016.135"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.637469"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2023-eular.7084"},{"issue":"9","key":"e_1_2_8_29_1","first-page":"2180","article-title":"Nanoencapsulated sirolimus plus pegadricase (NASP) demonstrates long term efficacy and safety in patients with uncontrolled gout: results from the 24\u2010week double\u2010blind extension of the phase 3 DISSOLVE I study","volume":"77","author":"Kivitz A","year":"2025","journal-title":"Arthritis Rheum"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199206000-00002"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq346"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23575"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40381"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.12.1303"},{"issue":"4","key":"e_1_2_8_35_1","first-page":"234","article-title":"Improved health\u2010related quality of life with effective disease\u2010modifying antirheumatic drugs: evidence from randomized controlled trials","volume":"14","author":"Strand V","year":"2008","journal-title":"Am J Manag Care"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-024-00697-8"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4589"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2010.533647"},{"key":"e_1_2_8_39_1","volume-title":"Prescribing information","author":"Krystexxa (pegloticase)","year":"2012"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.211285"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.05.017"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-025-00767-5"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00804-5"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5648"},{"issue":"5","key":"e_1_2_8_45_1","first-page":"53","article-title":"Update on imaging in gout: contrasting and comparing the role of dual\u2010energy computed tomography to traditional diagnostic and monitoring techniques","volume":"36","author":"Bayat S","year":"2018","journal-title":"Clin Exp Rheumatol."},{"key":"e_1_2_8_46_1","volume-title":"SF\u201036 Physical and Mental Health Summary Scales: A User's Manual","author":"Ware JE","year":"1994"},{"key":"e_1_2_8_47_1","volume-title":"Prescribing information","author":"Rapamune (sirolimus)","year":"2017"},{"key":"e_1_2_8_48_1","volume-title":"Summary of product characteristics","author":"Rapamune (sirolimus)","year":"2025"}],"container-title":["Arthritis &amp; Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.70266","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/art.70266","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.70266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:44:00Z","timestamp":1785498240000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/art.70266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":47,"alternative-id":["10.1002\/art.70266"],"URL":"https:\/\/doi.org\/10.1002\/art.70266","archive":["Portico"],"relation":{},"ISSN":["2326-5191","2326-5205"],"issn-type":[{"value":"2326-5191","type":"print"},{"value":"2326-5205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"2025-10-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"art.70266"}}